Prognostic factors in young women with endometrial carcinoma: A report of 20 cases and review of literature

International Journal of Gynecological Cancer

Volumn 10, Issue 3, 2000, Pages 212-222

  Yamazawa, K ^a   Seki, K ^a   Matsui, H ^a   Kihara, M ^a   Sekiya, S ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; Prognostic factors; Uterus; Young women

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0033870490     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010003212.x     Document Type: Article

References (47)

1. Clinico-pathological profile of endometrial carcinoma in young women (under 40 years of age)
2. Endometrial 2 Ccarcinoma in women 40 years of age or younger
3. Endometrial adenocarcinoma in women under 25 years of age
4. Endometrial adenocarcinoma in Stein-Leventhal syndrome
5. Aggressive endometrial cancer in a young patient
6. Adenocarcinoma of the endometrium in women 40 years of age or younger
7. Endometrial carcinoma in young women: A report of four cases
8. Complex endometrial hyperplasia and carcinoma in adolescents and young women 15-20 years of age: A report of 10 cases
9. Endometrial carcinoma in young women
10. Endometrial carcinoma in young women: A clinical profile
11. Endometrial carcinoma in young women taking oral contraceptive agents
12. Carcinoma of endometrium (FIGO stage I and II): Clinical features and management
13. Profile of women 45 years of age and younger with endometrial cancer
14. Endometrial cancer in premenopausal women 45 years and younger
15. Endometrial carcinoma occurring in patients under the age of 45 years
16. Endometrial carcinoma in women 45 years of age or younger
17. Endometrial carcinoma in premenopausal women: A clinicopathological Study
18. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
19. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: Report of seven cases and review of the literature
20. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy
21. Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma
22. Pregnancy following hormonal therapy for adenocarcinoma of the endometrium
23. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
24. Primary treatment of endometrial cancer with progestagen alone
25. Progestin therapy in lesions of the endometrium
26. Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient
27. Endometrial carcinoma stage I-grade II. Conservative treatment followed by a healthy twin pregnancy
28. Surgical staging in endometrial cancer: Clinical-pathological findings of a prospective study
29. Endometrial carcinoma: Results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters
30. Tumor size in endometrial cancer
31. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals
32. FIGO News. Corpus cancer staging
33. Evaluation of Criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma
34. Tumors of the uterine corpus and gestational trophoblastic sidease
35. The utility of the revised international federation of gynecology and obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system: A GOG study
36. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
37. Endometrial carcinoma in 45, X Turner's syndrome without hormone replacement therapy
38. Endometrial carcinoma
39. Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
40. The menopause: Benefits and risks of estrogen-progestogen repalcement therapy
41. Estrogen replacement on surgical stage I and II endometrial cancer survivors
42. Endometrioid carcinoma of the ovary: A clinicopathologic study of 75 cases
43. Two pathogenetic types of endometrial carcinoma
44. Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma
45. Prognostic significance of hormone receptors in endometrial cancer
46. Limited disease: Role of surgery
47. Endometrial cancer young women associated with polycystic ovaries in young women: Letters to the Case